Abrocitinib

Therapeutic indications

Abrocitinib is indicated for:

Moderate-to-severe atopic dermatitis

Population group: both men and women, only adults (18 - 65 years old)

Abrocitinib is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Abrocitinib is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Severe hepatic impairment

Hepatic failure stage IV

Active serious systemic infections, including tuberculosis (TB)

at least one of
Systemic infection
Tuberculosis

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: CIBINQO Film-coated tablet
< Previous: Overview
Next: Precautions >